Posts Tagged ‘stem cells’
Posted on April 24th, 2012
PATIENTS suffering from spinal cord injury may soon find help in the form of stem cells drawn from their own bone marrow, thanks to a research project from the University of Western Australia.
UWA Associate Professor Stuart Hodgetts and PhD student Sarah Lovett are using human bone marrow stem cells (BMSCs) to promote an endogenous host response after spinal cord injury (SCI), by isolating stromal cells found in a patient’s own bone marrow and transplanting them back into the injury site in animal models.
Posted on March 7th, 2012
One of the world’s leading researchers into spinal cord injuries says China could hold the key to a cure that he has been searching for since he met late actor Christopher Reeve in the 1990s.
US-based Doctor Wise Young first used the word “cure” in relation to his work after a conversation with Reeve, the Superman hero who became a quadriplegic in an equestrian accident in 1995.
Posted on October 12th, 2010
A California bio-tech company has begun testing an embryonic stem-cell drug treatment on a patient with spinal cord injuries, marking the first time a drug made with embryonic stem cells has been used on a human.
The patient was enrolled at Shepherd Center, a spinal cord and brain injury rehabilitation center in Atlanta.
Posted on October 6th, 2010
A provocative video of two rodents with spinal cord injuries was shown to an audience gathered Tuesday at the Detroit Marriot for the second day of the World Stem Cell Summit. One of the rodents dragged its left hind leg, suffered from incontinence and couldn’t stand. The other rodent had an injection of embryonic stem cells and appeared to have more mobility in its back legs.
Posted on September 24th, 2010
Northwestern Medicine is the first site open for enrollment in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury. Following the procedure, participants will receive rehabilitation treatment at The Rehabilitation Institute of Chicago (RIC).
Northwestern also is the lead site of the trial, sponsored by Geron Corporation. The trial eventually will include up to six other sites and enroll up to 10 participants nationally.